In this study, the effect of random vs. site-directed immobilization techniques on the performance of antibody-based HPLC columns was investigated using a single-domain camelid antibody (VHH) directed against methotrexate (MTX) as a model system. First, the high flow-through support material POROS-OH was activated with disuccinimidyl carbonate (DSC), and the VHH was bound in a random manner via amines located on the protein's surface. The resulting column was characterized by Frontal Affinity Chromatography (FAC). Then, two site-directed techniques were explored to increase column efficiency by immobilizing the antibody via its C-terminus, i.e., away from the antigen-binding site. In one approach, a tetra-lysine tail was added, and the antibody was immobilized onto DSC-activated POROS. In the second site-directed approach, the VHH was modified with the AviTag peptide, and a biotin-residue was enzymatically incorporated at the C-terminus using the biotin ligase BirA. The biotinylated antibody was subsequently immobilized onto NeutrAvidin-derivatized POROS. A comparison of the FAC analyses, which for all three columns showed excellent linearity (R(2)>0.999), revealed that both site-directed approaches yield better results than the random immobilization; the by far highest efficiency, however, was determined for the immunoaffinity column based on AviTag-biotinylated antibody. As proof of concept, all three columns were evaluated for quantification of MTX dissolved in phosphate buffered saline (PBS). Validation using UV-detection showed excellent linearity in the range of 0.04-12μM (R(2)>0.993). The lower limit of detection (LOD) and lower limit of quantification (LLOQ) were found to be independent of the immobilization strategy and were 40nM and 132nM, respectively. The intra- and inter-day precision was below 11.6%, and accuracy was between 90.7% and 112%. To the best of our knowledge, this is the first report of the AviTag-system in chromatography, and the first application of immunoaffinity chromatography for the analysis of MTX.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2016.01.021DOI Listing

Publication Analysis

Top Keywords

site-directed immobilization
8
three columns
8
excellent linearity
8
lower limit
8
antibody
6
site-directed
5
immobilization genetically
4
genetically engineered
4
engineered anti-methotrexate
4
anti-methotrexate antibody
4

Similar Publications

Transglutaminase 2 (TG2) is a uniquely versatile protein with diverse catalytic activities, such as transglutaminase, protein disulfide isomerase, GTPase and protein kinase, and participates in several biological processes. According to information available in the RBP2GO database, TG2 can act as an RNA-binding protein (RBP). RBPs participate in posttranscriptional gene expression regulation, therefore influencing the function of RNA, whereas RNA molecules can also modulate the biological activity of RBPs.

View Article and Find Full Text PDF

Improved recombinant expression of soluble cathepsin B and L in Escherichia coli.

Appl Microbiol Biotechnol

December 2024

Institute of Biochemistry, Department of Biotechnology and Enzyme Catalysis, University of Greifswald, Greifswald, Germany.

Cysteine cathepsins such as cathepsin B and L play an important role in numerous diseases like acute pancreatitis or SARS-CoV-2 and therefore have high potential for the development of new therapeutics. To be able to screen for potent and selective inhibitors sufficient amounts of protein are required. Here, we present an easy and efficient protocol for the recombinant expression of soluble and active murine cathepsin B and L.

View Article and Find Full Text PDF
Article Synopsis
  • * A successful mutant enzyme, T1, demonstrated a 2.7-fold increase in activity compared to the wild type, with structural modifications leading to better interactions with the substrate.
  • * When combined in a multienzyme system, the modified CDH significantly improved cellulose degradation rates, showcasing potential for efficient straw biomass conversion with academic and practical relevance.
View Article and Find Full Text PDF

A Microbial Cocaine Bioreporter.

Sensors (Basel)

October 2024

Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

The continuous emergence of new illegal compounds, particularly psychoactive chemicals, poses significant challenges for current drug detection methods. Developing new protocols and kits for each new drug requires substantial time, effort, and dedicated manpower. Whole-cell bacterial bioreporters have been proven capable of detecting diverse hazardous compounds in both laboratory and field settings, identifying not only single compounds but also chemical families.

View Article and Find Full Text PDF

Precise Immobilization Strategy Combined with Rational Design to Improve β-Agarase Stability.

J Agric Food Chem

October 2024

The State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi 214122, China.

Article Synopsis
  • Recent advancements focus on the precise site-specific immobilization of enzymes, specifically β-agarase, using a combination of rational design and mutation.* -
  • By mutating specific surface sites to cysteine, researchers successfully achieved covalent binding with maleimide-modified magnetic nanoparticles, maintaining over 96% enzyme activity.* -
  • This strategy not only improves the enzyme's thermal stability and tolerance to solvents, but also contributes to environmentally friendly manufacturing processes.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!